Results 181 to 190 of about 341,080 (292)

Real‐world characteristics and treatment of cardiac transthyretin amyloidosis: A multicentre, observational study

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1203-1216, April 2025.
The 366 patients diagnosed with transthyretin amyloidosis cardiomyopathy (ATTR‐CM) were analyzed regarding their clinical characteristics in the first year after approval of tafamidis 61 mg for ATTR‐CM in Germany. Nearly two‐thirds of the patients were in an advanced disease stage and 64% met the key criteria of the “Transthyretin Amyloidosis ...
Richard J. Nies   +23 more
wiley   +1 more source

Subclinical myocardial changes in idiopathic premature ventricular contractions: insights from cardiac magnetic resonance imaging. [PDF]

open access: yesFront Cardiovasc Med
Yazaki Y   +9 more
europepmc   +1 more source

Considerations for drug trials in hypertrophic cardiomyopathy

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant   +17 more
wiley   +1 more source

Silent Inferolateral Postinfarction Left Ventricular Outpouching With Thrombus: Cardiac Magnetic Resonance Assessment. [PDF]

open access: yesJACC Case Rep
Alanís-Naranjo JM   +8 more
europepmc   +1 more source

Cardiac Magnetic Resonance Fingerprinting

open access: yesJACC: Cardiovascular Imaging, 2018
Yuchi Liu   +3 more
openaire   +1 more source

Association of BMI with adherence and outcome in heart failure patients treated with wearable cardioverter defibrillator

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1295-1303, April 2025.
Abstract Background Obesity is a known risk factor for cardiovascular disease (CVD), yet an ‘obesity paradox’ has been observed in various CVD contexts. The impact of obesity on heart failure (HF) patients treated with a wearable cardioverter‐defibrillator (WCD) remains underexplored.
Mohammad Abumayyaleh   +18 more
wiley   +1 more source

Cardiac magnetic resonance characteristics of pediatric Cardiac Teratoma

open access: yesJournal of Cardiovascular Magnetic Resonance, 2012
Tipton Amy L   +6 more
doaj   +1 more source

Cardiac magnetic resonance characteristics and prognostic associations of hypertension-mediated left ventricular hypertrophy. [PDF]

open access: yesEur Heart J Imaging Methods Pract
Naderi H   +7 more
europepmc   +1 more source

Takotsubo cardiomyopathy during armed conflict: A case series

open access: yes
ESC Heart Failure, Volume 12, Issue 2, Page 1494-1498, April 2025.
Sharon Bruoha   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy